VANI Stock Summary and Trading Ideas (Vivani Medical | NASDAQ:VANI)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

Vivani Medical trades on the NASDAQ stock market under the symbol VANI.

As of January 23, 2026, VANI stock price climbed to $1.48 with 176,536 million shares trading.

VANI has a beta of 0.96, meaning it tends to be less sensitive to market movements. VANI has a correlation of 0.11 to the broad based SPY ETF.

VANI has a market cap of $107.97 million. This is considered a Micro Cap stock.

In the last 3 years, VANI traded as high as $7.80 and as low as $.75.

The top ETF exchange traded funds that VANI belongs to (by Net Assets): VTI, VXF, IWC.

VANI has outperformed the market in the last year with a price return of +21.3% while the SPY ETF gained +14.9%. However, in the short term, VANI had mixed performance relative to the market. It has underperformed in the last 3 months, returning -11.4% vs +3.5% return in SPY. But in the last 2 weeks, VANI shares have fared better than the market returning +13.0% compared to SPY 0.0%.

VANI support price is $1.41 and resistance is $1.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VANI shares will trade within this expected range on the day.